NCT00200382View on ClinicalTrials.gov

Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

PS-341 (Velcade-drug)

Trial Locations (5)

10461

Albert Einstein Cancer Center, The Bronx

Jacobi Medical Center, The Bronx

10467

Montefiore Medical Center, The Bronx

01420

HealthAlliance Hospitals, Fitchburg

03756

Dartmouth-Hitchcock Medical Center, Lebanon

Sponsors
All Listed Sponsors
collaborator

Millennium Pharmaceuticals, Inc.

INDUSTRY

lead

Rasim Gucalp

OTHER